Congratulations to Drs. Poul Sorensen and Gregg Morin, at BC Cancer, and Dr. Wei Li, at the University of Pittsburgh, for being awarded $500,000 USD from the Osteosarcoma Institute for their project titled “Harnessing the osteosarcoma surfaceome for immunotherapy targets to block metastatic capacity”
Dr. Poul Sorensen, Distinguished Scientist at BC Cancer, in collaboration with Dr. Kevin Hay, Clinician-Ccientist at BC Cancer, and Dr. Wei Li, Assistant Professor at the University of Pittsburgh, received support from the Rutledge Cancer Foundation to develop and optimize novel immunotherapies targeting the surface protein IL1RAP for the treatment of Ewing sarcoma.
We are thrilled to announce that Dr. Florian Kuchenbauer, distinguished scientist of Terry Fox Laboratory (Kuchenbauer Lab) and associate professor at University of British Columbia, has been honored with the Outstanding Academic Performance (OAP) award from the UBC Faculty of Medicine in 2022.
Students of Dr. Xiaoyan Jiang, Andrew Wu and Ryan Yen (Collings Stevens Laboratory), along with a team of researchers, have published a paper in Leukemia Journal titled, "Identification of Multivariable microRNA and Clinical Biomarker Panels to Predict Imatinib Response in Chronic Myeloid Leukemia at Diagnosis."
Congratulations to Dr. Hossein Rafiei, Michelle Yeung, Dr. Sara Kowalski, Dr. Gerald Krystal and Dr. Ingrid Elisia for their new publication titled, "Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis" in the Frontiers in Pharmacology journal, October 2023.
Congratulations to Dr. Amanda Amoah (Kuchenbauer Lab), for receiving the Walter Benjamin German Research Foundation (DFG) fellowship for the work titled "Characterization of miR-106a in inv(3)/t(3;3) AML and its exploitation as an avenue for treatment".
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.